Your browser doesn't support javascript.
loading
Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG.
Fiegl, M; Unterhalt, M; Kern, W; Braess, J; Spiekermann, K; Staib, P; Grüneisen, A; Wörmann, B; Schöndube, D; Serve, H; Reichle, A; Hentrich, M; Schiel, X; Sauerland, C; Heinecke, A; Rieger, C; Beelen, D; Berdel, W E; Büchner, T; Hiddemann, W.
Afiliación
  • Fiegl M; Department of Internal Medicine III, University Hospital of Munich, Munich, Germany.
  • Unterhalt M; Department of Internal Medicine III, University Hospital of Munich, Munich, Germany.
  • Kern W; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Braess J; Department of Hematology and Oncology, Klinikum Barmherzige Brüder, Regensburg, Germany.
  • Spiekermann K; Department of Internal Medicine III, University Hospital of Munich, Munich, Germany.
  • Staib P; Department of Hematology and Oncology, St-Antonius-Hospital, Eschweiler, Germany.
  • Grüneisen A; Department of Hematology and Oncology, Vivantes Klinikum Berlin-Neukölln, Berlin, Germany.
  • Wörmann B; German Society for Hematology and Oncology, Berlin, Germany.
  • Schöndube D; Department of Hematology and Oncology, Helios Klinikum Berlin Buch, Berlin, Germany.
  • Serve H; Department of Hematology and Oncology, J.W. Goethe-University, Frankfurt, Germany.
  • Reichle A; Department of Internal Medicine II, University Hospital of Regensburg, Regensburg, Germany.
  • Hentrich M; Department of Hematology and Oncology, Krankenhaus Harlaching, Munich, Germany.
  • Schiel X; Department of Hematology and Oncology, Krankenhaus Harlaching, Munich, Germany.
  • Sauerland C; Institute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany.
  • Heinecke A; Institute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany.
  • Rieger C; Department of Internal Medicine III, University Hospital of Munich, Munich, Germany.
  • Beelen D; Department of Hematopoietic Stem Cell Transplantation, University of Essen, Essen, Germany.
  • Berdel WE; Department of Medicine A, Hematology and Oncology, University of Muenster, Muenster, Germany.
  • Büchner T; Department of Medicine A, Hematology and Oncology, University of Muenster, Muenster, Germany.
  • Hiddemann W; Department of Internal Medicine III, University Hospital of Munich, Munich, Germany.
Leukemia ; 28(5): 1001-7, 2014 May.
Article en En | MEDLINE | ID: mdl-24150216

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2014 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2014 Tipo del documento: Article País de afiliación: Alemania